| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Feb―10 |
A205 IMPACT OF THE PANDEMIC ON BUDESONIDE MMX DISPENSING AND TREATMENT FAILURE IN ULCERATIVE COLITIS |
S Coward, K Martins, S Klarenbach, K Kroeker, C Ma, R Panaccione, et al. (+4) L Richer, C Seow, L Targownik, G G Kaplan |
| 2 |
[GO] |
2025―Feb―10 |
A65 HOSPITALIZATION RATES OF INFLAMMATORY BOWEL DISEASE DURING THE COVID-19 PANDEMIC: A POPULATION-BASED STUDY OF THE ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT. |
L M Wilson, J A King, E Buie, S Coward, A Shaheen, G G Kaplan |
| 3 |
[GO] |
2025―Feb―10 |
A222 PATTERNS OF SPECIALIST HEALTHCARE DELIVERY AMONG INFLAMMATORY BOWEL DISEASE PATIENTS IN RESPONSE TO THE COVID-19 PANDEMIC IN ONTARIO |
L J Nguyen, V Huang, P Habashi, P Tandon |
| 4 |
[GO] |
2024―Feb―16 |
A295 A CHALLENGING DIAGNOSTIC CASE - SEVERE ACUTE HEPATITIS POTENTIALLY ASSOCIATED WITH COVID-19 IN AN IMMUNOCOMPETENT YOUNG ADULT |
B Lawendy, D Hudson, R Abdul-Karim |
| 5 |
[GO] |
2024―Feb―16 |
A274 COVID-19 INFECTION RISK BETWEEN VACCINATED PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE : A RETROSPECTIVE COHORT STUDY IN TAIWAN |
Y WU, J Chou |
| 6 |
[GO] |
2024―Feb―16 |
A168 RATES OF CLOSTRIDIOIDES DIFFICILE INFECTIONS REQUIRING HOSPITALIZATION DURING THE COVID-19 PANDEMIC |
J Besney, K Buhler, G G Kaplan, C Lu, C Seow, K Novak, et al. (+2) R Panaccione, C Ma |
| 7 |
[GO] |
2024―Feb―16 |
A174 TESTING FOR AND INCIDENCE OF CELIAC DISEASE AUTOIMMUNITY SAW SIGNIFICANT BUT TEMPORARY DECLINES DURING COVID-19 PANDEMIC |
J A King, S Coward, G G Kaplan, T Williamson |
| 8 |
[GO] |
2024―Feb―16 |
A175 IMPACT OF THE COVID-19 PANDEMIC ON CANADIANS WITH CELIAC DISEASE |
J A King, C McAulay, M Secord, M Pinto-Sanchez, J Turner, D Gidrewicz, et al. (+2) S Case, D Duerksen |
| 9 |
[GO] |
2024―Feb―16 |
A71 IMPACT OF THE COVID-19 PANDEMIC ON WAIT TIMES, AND CLINICALLY RELEVANT FINDINGS AT COLONOSCOPY |
A Barkun, K Ravanbakhsh, D Kim, G Milky, P Stanowski, O Geraci, et al. (+3) M Martel, C Menard, D von Renteln |
| 10 |
[GO] |
2024―Feb―16 |
A113 COVID-19 VACCINATIONS IN IBD PATIENTS: PATIENT KNOWLEDGE AND PERCEPTIONS |
A Saunders, L Hill, D Armstrong, J Marshall, N Narula, N Pai, U Chauhan |
| 11 |
[GO] |
2024―Jan―23 |
The impact of source and consumption of news on mental distress among inflammatory bowel disease patients during the COVID-19 pandemic |
Seth R Shaffer, Casandra Dolovich, Renée El-Gabalawy, Lesley A Graff, Harminder Singh, Gia L Jackson, et al. (+3) Sydney Chochinov, Souradet Shaw, Charles N Bernstein |
| 12 |
[GO] |
2023―Nov―13 |
The Impact of COVID-19 on Health Anxiety and Perceived Stress Among Persons with IBD: A Population-representative Study |
Seth R Shaffer, Gia L Jackson, Sydney Chochinov, Casandra Dolovich, Lesley A Graff, Renée El-Gabalawy, et al. (+3) Souradet Yuh-Nan Shaw, Harminder Singh, Charles N Bernstein |
| 13 |
[GO] |
2023―Okt―10 |
How Did COVID-19 Affect Mental Health and Access to Care in Persons With Inflammatory Bowel Disease |
Seth R Shaffer |
| 14 |
[GO] |
2023―Sep―08 |
The Association Between Increased Maladaptive Health Behaviours and Elevated Mental Health Symptoms Among Persons with IBD During the COVID-19 Pandemic |
Casandra L Dolovich, Seth R Shaffer, Lesley A Graff, Harminder Singh, Renée El-Gabalawy, Souradet Shaw, Charles N Bernstein |
| 15 |
[GO] |
2023―Sep―05 |
The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD |
Gilaad G Kaplan, M Ellen Kuenzig, Joseph W Windsor, Charles N Bernstein, Alain Bitton, Stephanie Coward, et al. (+26) Jennifer L Jones, Kate Lee, Sanjay K Murthy, Laura E Targownik, Juan-Nicolás Peña-Sánchez, Sara Ghandeharian, Noelle Rohatinsky, Jake Weinstein, Tyrel Jones May, Mira Browne, Nazanin Jannati, Sahar Tabatabavakili, James H B Im, Saketh Meka, Sonya Vukovic, Tal Davis, Quinn Goddard, Julia Gorospe, Taylor Stocks, Léa Caplan, Najla Kanaan, Daniel Stuart, Tesa Ramsay, Kelly J Robinson, Diane Charron-Bishop, Eric I Benchimol |
| 16 |
[GO] |
2023―Mrz―07 |
A248 OUTCOMES OF COVID-19 ILLNESS AND ACCESS TO APPROPRIATE TREATMENT IN LIVER TRANSPLANT RECIPIENTS IN BRITISH COLUMBIA THROUGHOUT THE PANDEMIC |
J Reid, E Yoshida, T Hussaini, J -A Harrigan |
| 17 |
[GO] |
2023―Mrz―07 |
A188 INFORMING IMMUNOCOMPROMISED POPULATIONS: AN EFFECTIVE AND EFFICIENT COVID-19 KNOWLEDGE TRANSLATION STRATEGY |
J W Windsor, S Coward, K Lee, A Specic, S Ghandeharian, E I Benchimol, G G Kaplan |
| 18 |
[GO] |
2023―Mrz―07 |
A193 DEMOGRAPHIC, SOCIAL AND OCCUPATIONAL FACTORS THAT PREVENTED EXPOSURE TO SARS-COV-2 IN INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC: A PROSPECTIVE COHORT STUDY |
L N Caplan, N Sharifi, A Markovinovic, M Herauf, J Quan, L Hracs, et al. (+6) J W Windsor, S Coward, C Ma, R Panaccione, B Hagel, G G Kaplan |
| 19 |
[GO] |
2023―Mrz―07 |
A177 RISK OF VENOUS THROMBOEMBOLISM IN COVID-19 PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED MATCHED COHORT STUDY |
R Khan, E Kuenzig, A Tang, J Im, J Widdifield, J McCurdy, et al. (+2) G Kaplan, E Benchimol |
| 20 |
[GO] |
2023―Mrz―07 |
A254 HEPATIC SEQUELAE OF POST-ACUTE COVID-19 SYNDROME (PACS): A SYSTEMATIC REVIEW OF THE CURRENT LITERATURE |
P Mundra, Z Kailani, M Yaghoobi, S Albashir |
| 21 |
[GO] |
2023―Mrz―07 |
A69 ASSESSING COVID-19 VACCINATION COMPLIANCE AND HESITANCY IN THE EARLY ADULT (18-25YRS) INFLAMMATORY BOWEL DISEASE (IBD) POPULATION |
A Ramkissoon, Z Mohmand, N Bollegala |
| 22 |
[GO] |
2023―Mrz―07 |
A13 THE RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINATION IS SIMILAR IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC POPULATION: RESULTS OF A LARGE INTERNATIONAL CROSS-SECTIONAL STUDY |
S Tandon, J P Stefanolo, L Russell, M D L Paz Temprano, S Niveloni, E Verdu, et al. (+19) D Armstrong, B Lebwohl, D Leffler, J Tye-Din, A Day, C Olano, V Lopez, L Uzcanga, E Madaria, M Montoro Huguet, S Vivas, A Rodriguez-Herrera, G Makharia, D Sanders, J Zeitz, C Mulder, C Ciacci, F Valerio, M I Pinto-Sanchez |
| 23 |
[GO] |
2023―Mrz―07 |
A63 TRENDS AND OUTCOMES OF LIVER DISEASE HOSPITALIZATIONS DURING THE CORONAVIRUS PANDEMIC IN THE UNITED STATES: A NATIONWIDE POPULATION-LEVEL ANALYSIS |
M Sedarous, M Youssef, A D Adekunle, O Babajide, M Rubens, P N Okafor |
| 24 |
[GO] |
2023―Mrz―07 |
A170 ADVERSE EVENTS & SEROLOGICAL RESPONSES FOLLOWING SARS-COV-2 VACCINATION IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE |
A Markovinovic, M Herauf, J Quan, L Hracs, J W Windsor, N Sharifi, et al. (+14) S Coward, L Caplan, J Gorospe, C Ma, R Panaccione, R Ingram, J Kanji, G Tipples, J Holodinsky, C Berstein, D Mahoney, S Bernatsky, E Benchimol, G G Kaplan |
| 25 |
[GO] |
2023―Mrz―07 |
A195 DURABILITY OF SEROLOGICAL RESPONSES AFTER SECOND, THIRD AND FOURTH DOSE OF SARS-COV-2 VACCINATION IN INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY |
N Sharifi, C Ma, C Seow, J Quan, L Hracs, L Caplan, et al. (+8) A Markovinović, M Herauf, J Windsor, S Coward, M Buie, J Gorospe, R Panaccione, G Kaplan |
| 26 |
[GO] |
2022―Jul―18 |
Survey of the Impact of COVID-19 on Chronic Liver Disease Patient Care Experiences and Outcomes |
Shirley X Jiang, Katerina Schwab, Robert Enns, Hin Hin Ko |
| 27 |
[GO] |
2022―Jun―25 |
Increased Hospitalization for IBD Patients Seen in the ER During the COVID-19 Pandemic |
Gurpreet Malhi, Gurjot Minhas, Jason Chambers, Maria Mikail, Reena Khanna, Aze Wilson |
| 28 |
[GO] |
2022―Feb―21 |
A180 CLINICAL OUTCOMES OF COVID-19 AND IMPACT ON DISEASE COURSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
P Wetwittayakhlang, F Albader, P Golovics, G Drügg Hahn, T Bessissow, A Bitton, et al. (+3) W Afif, G Wild, P L Lakatos |
| 29 |
[GO] |
2022―Feb―21 |
A209 EXPERT CONSENSUS CRITERIA AND PRACTICAL RECOMMENDATIONS FOR PBC CARE IN THE COVID-19 ERA AND BEYOND |
G Hirschfield, M Berenguer, A E Kremer, D Jones, V Leroy, F Adekunle, M Carbone |
| 30 |
[GO] |
2022―Feb―21 |
A224 COVID-19 INFECTION IN LIVER TRANSPLANT RECIPIENTS: CLINICAL FEATURES, HOSPITALIZATION, AND MORTALITY FROM A CANADIAN MULTICENTRE COHORT |
M K Smith, J Chow, R Huang, M Omar, M Ebadi, P Wong, et al. (+6) G Huard, E M Yoshida, D Peretz, M Brahmania, A J Montano-Loza, R Bhanji |
| 31 |
[GO] |
2022―Feb―21 |
A25 CRITICAL APPRAISAL OF GI ENDOSCOPY CLINICAL PRACTICE GUIDELINES DURING THE COVID-19 PANDEMIC |
D Tham, N Gimpaya, R Gholami, C Pattni, S Seleq, R Bansal, et al. (+7) M A Fujiyoshi, A Ramkissoon, J Lisondra, J Ariaratnam, M Scaffidi, R Khan, S Grover |
| 32 |
[GO] |
2022―Feb―21 |
A82 DELIVERY OF AMBULATORY CARE DURING THE COVID-19 PANDEMIC IN THE DIVISION OF DIGESTIVE CARE & ENDOSCOPY, HALIFAX, NS |
J Francheville, P Koto, K Peltekian |
| 33 |
[GO] |
2022―Feb―21 |
A253 IMPACT OF THE COVID-19 PANDEMIC LOCKDOWN ON PHYSICAL ACTIVITY LEVELS IN CHILDREN AND ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE IN QUEBEC |
J Bouthot, L Dehbidi Assadzadeh, L Belmesk, S Madagh, S Geng, C Deslandres, P Jantchou |
| 34 |
[GO] |
2022―Feb―21 |
A22 IMPACT OF COVID-19 PANDEMIC ON FOREIGN BODY INGESTION IN CHILDREN AND ADOLESCENTS: A CROSS-SECTIONAL STUDY |
Y Zhao, L Dehbidi Assadzadeh, A Gallant, S Gorenko-Lévêque, A Chekkal, B Djoukam Mbuko, et al. (+9) N Pierre, M Dirks, V Groleau, A Lapointe, D Ngwanou, N Piché, C Deslandres, J Gravel, P Jantchou |
| 35 |
[GO] |
2022―Feb―21 |
A202 IMPACT OF THE COVID-19 PANDEMIC ON THE EPIDEMIOLOGY OF ALCOHOL-RELATED HEPATITIS |
A Frolkis, M Borman, M D Sadler, S E Congly, H H Nguyen, S Lee, et al. (+6) L Stinton, M Swain, C S Coffin, A Aspinall, K W Burak, A M Shaheen |
| 36 |
[GO] |
2022―Feb―21 |
A96 RAPID IMPLEMENTATION OF AN EVIDENCE-BASED, VIRTUAL COVID-19 VACCINE EDUCATION CLINIC AT NOVA SCOTIA COLLABORATIVE INFLAMMATORY DISEASE CLINIC (NSCIBD) |
H Komeylian, J Jones, M Stewart, C Heisler, K Phalen-Kelly, B Currie |
| 37 |
[GO] |
2022―Feb―21 |
A132 ACHALASIA FOLLOWING A SARS-COV-2 INFECTION: A CASE REPORT |
E Zeidan, E Desilets, M Bouin, T Maniere |
| 38 |
[GO] |
2022―Feb―21 |
A45 INFLIXIMAB IN COMBINATION WITH AN IMMUNOMODULATOR IS ASSOCIATED WITH AN ATTENUATED ANTIBODY RESPONSE TO BNT162B2 SARS-COV-2 VACCINE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS |
S Lawrence, Z Shire, F Reicherz, P Lavoie, K Jacobson |
| 39 |
[GO] |
2022―Feb―21 |
A214 SIMPLIFICATION OF CARE FOR HCV IS EFFECTIVE DURING THE COVID PANDEMIC: A RETROSPECTIVE STUDY OF HCV TREATMENT UTILIZING THE BRITISH COLUMBIA HEPATITIS C NETWORK |
S X Jiang, J Feizi Farivar, J MacIsaac, E Tam, M Choi, P Luyun, et al. (+2) H Ko, A Ramji |
| 40 |
[GO] |
2021―Mrz―09 |
A85 THE CLINICAL IMPACT OF COVID-19 DELAYS ON PLASTIC BILIARY STENT REMOVAL IN NOVA SCOTIA |
D R Lim, M Tsai, S E Gruchy, J Jones, G Williams, D Farina, A R Kohansal |
| 41 |
[GO] |
2021―Mrz―09 |
A11 RISK PERCEPTION AND KNOWLEDGE OF COVID-19 IN PATIENTS WITH CELIAC DISEASE |
J Zhen, J Stefanolo, M Montoro, L Uscanga, A Day, J Tye-Din, et al. (+3) C Ciacci, B Lebwohl, M I Pinto-Sanchez |
| 42 |
[GO] |
2021―Mrz―09 |
A176 THE IMPACT OF COVID-19 ON ANXIETY, DEPRESSION, AND STRESS IN WOMEN WITH INFLAMMATORY BOWEL DISEASE: A CROSS-SECTIONAL SURVEY |
P Tandon, K O’Connor, C Maxwell, G C Nguyen, V W Huang |
| 43 |
[GO] |
2021―Mrz―09 |
A103 PIVOTING IN A PANDEMIC: THE IMPACT OF COVID-19 ON THE PROVISION OF CARE FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PRELIMINARY ANALYSIS |
G Malhi, M Mikail, G Minhas, J Chambers, R Khanna, A Wilson |
| 44 |
[GO] |
2021―Mrz―09 |
A77 A REUSABLE POLYCARBONATE BOX TO DECREASE DROPLET CONTAMINATION DURING UPPER ENDOSCOPY: A SIMULATION-BASED STUDY FOR THE COVID-19 PANDEMIC |
N Gimpaya, R Khan, Z R Gallinger, M A Scaffidi, A K Al Abdulqader, M Ahmed, et al. (+7) R Gholami, A Ramkissoon, P D James, J Mosko, N Griller, R Bansal, S C Grover |
| 45 |
[GO] |
2021―Mrz―09 |
A86 INFLAMMATORY BOWEL DISEASE PATIENTS’ SATISFACTION WITH TELEHEALTH: DURING THE COVID-19 PANDEMIC |
M Painchaud, S Singh, R M Penner |
| 46 |
[GO] |
2021―Mrz―09 |
A87 HEALTHCARE PROVIDER SATISFACTION WITH VIRTUAL CARE DELIVERY IN ALBERTA DURING THE COVID-19 PANDEMIC. |
L Olayinka, G G Kaplan, L Reeb, R Panaccione, K Kroeker |
| 47 |
[GO] |
2021―Mrz―09 |
A92 PREVIOUS VIRTUAL CONSULTATION EXPERIENCE IS RELATED TO PRECEPTOR’S WILLINGNESS TO INVOLVE TRAINEES IN VIRTUAL CARE DURING THE COVID-19 PANDEMIC |
L Olayinka, G G Kaplan, L Reeb, R Panaccione, K Kroeker |
| 48 |
[GO] |
2021―Mrz―09 |
A80 IMPACT OF THE COVID-19 PANDEMIC IN IBD PATIENT CARE |
M Dahiya, L Olayinka, G G Kaplan, L Reeb, C Ma, R Panaccione, K Kroeker |
| 49 |
[GO] |
2021―Mrz―09 |
A69 THE EFFECT OF COVID-19 PANDEMIC ON CURRENT AND FUTURE ENDOSCOPIC PERSONAL PROTECTIVE EQUIPMENT PRACTICES: A NATIONAL SURVEY OF 77 ENDOSCOPISTS |
W Sun, M El Hafid, J Dang, V Mocanu, G Lutzak, R Sultanian, et al. (+2) C Wong, S Karmali |
| 50 |
[GO] |
2021―Mrz―09 |
A173 INNOVATIVE CARE FOR INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC: USE OF BEDSIDE INTESTINAL ULTRASOUND TO OPTIMIZE MANAGEMENT |
K L Novak, C Ma, H Kheirkhahrahimabadi, j heatherington, R Ingram, M Martin, et al. (+6) R Panaccione, G G Kaplan, S Devlin, C Seow, M Chan, C Lu |
| 51 |
[GO] |
2021―Mrz―09 |
A239 AN APPROACH TO GASTRIC BALLOON RETRIEVAL ADMIDST COVID-19 RELATED TRAVEL RESTRICTIONS |
M Dahiya, M Tomaszewski, A Bond, F Donnellan, R Mohamed |
| 52 |
[GO] |
2021―Mrz―09 |
A107 IMPROVING ACCESS TO URGENT GASTROENTEROLOGICAL CONSULTATION: A POSITIVE PANDEMIC IMPACT |
M J Stewart, A R Kohansal, K Peltekian, J Jones |
| 53 |
[GO] |
2020―Mrz―25 |
COVID-19: Advice from the Canadian Association of Gastroenterology for Endoscopy Facilities, as of March 16, 2020 |
Frances Tse, Mark Borgaonkar, Grigorios I Leontiadis |
|
